Northwestern, AbbVie partner to research cancer therapies

A new collaboration between two Chicago healthcare entities will provide a platform to conduct ongoing cancer research.

AbbVie and Northwestern University have agreed to a five-year collaboration in which Northwestern’s Lurie Cancer Center will be able to access new therapies made by AbbVie. The collaboration will focus on lung, colorectal, breast, prostate and blood cancers, according to a recent report from Crain’s Chicago Business.

In addition to working with Northwestern, AbbVie has announced similar collaborations with Johns Hopkins University School of Medicine in Baltimore and the University of Chicago.

To read more about the partnerships, follow the link below:

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The mobile power units of certain HeartMate 3 and HeartMate II LVADs have been experiencing “sudden, unexpected performance issues” such as turning on, off or even restarting with no warning. These issues can potentially be fatal, according to an alert shared by the FDA.

Radiology practices are already operating on razor thin margins, with price increases prompting calls for congressional action to prevent further damage. 

United Imaging and other manufacturers that have established American factories may remain insulated from the trade war.